Elms Steve

Director at ADMA; Director, 10% owner at Loxo Oncology, Inc.; Director at MAP Pharmaceuticals, Inc.

Sold, on record
$55.5M
Dollars the filings state
Form 4 sales
5
Latest Jun 16, 2025
Form 144 notices
1
Proposed sales
Quarters with a sale
1 of the last 8
1 day with a sale in that time
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
1
Plan not stated
2
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. Jun 16, 2025No plan

    ADMA

    Sold 17.3% of their holdings

    $8.8M425,621 shares at $20.74

    Filed Jun 16, 2025Form 4

  2. Jun 12, 2025Notice

    ADMA

    Filed a notice to sell 425,621 shares

    $9.3M425,621 shares

    Filed Jun 12, 2025Form 144

  3. Mar 19, 2024No plan

    ADMA

    Sold 17.9% of their holdings

    $2.8M461,716 shares at $6.07

    Filed Mar 19, 2024Form 4

  4. Mar 15, 2024Unusual

    ADMA

    Sold 28.7% of their holdings

    $6.3M1M shares at $6.11

    Filed Mar 15, 2024Form 4

  5. Nov 22, 2017Plan not stated

    Loxo Oncology, Inc.

    Sold 11.9% of their holdings

    $37.5M500,000 shares at $75.00

    Filed Nov 27, 2017Form 4

  6. Mar 10, 2010Unusual

    MAP Pharmaceuticals, Inc.

    Sold 100% of their holdings

    $34k2,090 shares at $16.15

    Filed Mar 12, 2010Form 4

6 of 6

Every transaction

Every transaction on a Form 4 or Form 5 by Elms Steve
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Mar 6, 2026Mar 9, 2026ADMADirectorBought14,000$15.53$217k2MSEC
Feb 9, 2026Feb 11, 2026ADMADirectorAwardedStock Option (Right to Buy)17,73017,730SEC
Feb 9, 2026Feb 11, 2026ADMADirectorAwarded10,69098,020SEC
Nov 17, 2025Nov 19, 2025MRKRDirectorAwardedStock Option (right to buy)221,741137,330SEC
Jul 23, 2025Jul 24, 2025Elevation Oncology, Inc.DirectorReturned to the companyStock Option (Right to Buy)148,0950SEC
Jun 16, 2025Jun 16, 2025ADMADirectorSold425,621$20.74$8.8M87,330SEC
Jun 13, 2025Jun 16, 2025ADMADirectorExercised or settledStock Option (Right to Buy)332,6800SEC
Jun 13, 2025Jun 16, 2025ADMADirectorExercised options332,680$3.43$1.1M420,010SEC
Jun 5, 2025Jun 9, 2025Elevation Oncology, Inc.DirectorAwardedStock Option (Right to Buy)35,00035,000SEC
Feb 19, 2025Feb 21, 2025ADMADirectorAwardedStock Option (Right to Buy)16,27916,279SEC
Feb 19, 2025Feb 21, 2025ADMADirectorAwarded10,88987,330SEC
Feb 12, 2025Feb 14, 2025MRKRDirectorAwardedStock Option (right to buy)30,00030,000SEC
Dec 23, 2024Dec 26, 2024MRKRDirectorBought11,085$3.20$35k325,370SEC
Nov 27, 2024Dec 2, 2024ADMADirectorExercised or settledStock Option (Right to Buy)9,0000SEC
Nov 27, 2024Dec 2, 2024ADMADirectorExercised options9,000$10.80$97k2.1MSEC
Jun 13, 2024Jun 17, 2024Elevation Oncology, Inc.DirectorAwardedStock Option (Right to Buy)35,00035,000SEC
Mar 19, 2024Mar 19, 2024ADMADirectorSold461,716$6.07$2.8M2.1MSEC
Mar 15, 2024Mar 15, 2024ADMADirectorSold1M$6.11$6.3M2.6MSEC
Feb 26, 2024Feb 28, 2024ADMADirectorAwardedStock Option (right to buy)37,54137,541SEC
Feb 26, 2024Feb 28, 2024ADMADirectorAwarded24,04076,441SEC
Jun 6, 2023Jun 8, 2023MRKRDirectorAwardedStock Option (right to buy)8,0008,000SEC
Mar 6, 2023Mar 8, 2023ADMADirectorAwardedEmployee Stock Option (right to buy)51,63051,630SEC
Mar 6, 2023Mar 8, 2023ADMADirectorAwarded25,81552,401SEC
May 24, 2022May 26, 2022MRKRDirectorAwardedStock Option (Right to Buy)80,00080,000SEC
Mar 7, 2022Mar 9, 2022ADMADirectorAwardedEmployee Stock Option (right to buy)53,17253,172SEC
Mar 7, 2022Mar 9, 2022ADMADirectorAwarded26,58626,586SEC
Jun 10, 2021Jun 14, 2021Zosano Pharma CorpDirectorAwardedStock Option (Right to Buy)30,00030,000SEC
Jun 10, 2021Jun 14, 2021Zosano Pharma CorpDirectorAwarded15,00022,500SEC
Jun 8, 2021Jun 10, 2021MRKRDirectorAwarded12,65829,680SEC
Mar 16, 2021Mar 18, 2021MRKRDirectorBought1.1M$1.75$2M3.1MSEC
Feb 25, 2021Mar 1, 2021ADMADirectorAwardedStock Option (right to buy)55,00055,000SEC
Jun 25, 2020Jun 29, 2020Zosano Pharma CorpDirectorAwarded7,5007,500SEC
Jun 3, 2020Jun 5, 2020Zosano Pharma CorpDirectorAwardedStock Option (Right to Buy)15,00015,000SEC
May 19, 2020Feb 12, 2021MRKRDirectorAwarded17,02217,022SEC
Feb 28, 2020Mar 3, 2020ADMADirectorAwardedEmployee Stock Option (right to buy)15,00015,000SEC
Feb 28, 2020Mar 3, 2020ADMADirectorAwarded7,5007,500SEC
Aug 6, 2019Aug 8, 2019MRKRDirectorAwardedStock Option (right to buy)12,50012,500SEC
Apr 11, 2019Apr 12, 2019Zosano Pharma Corp10% ownerAwarded428,571$3.50$1.5M2MSEC
Mar 13, 2019Mar 15, 2019ADMADirectorAwardedStock Option (right to buy)30,00030,000SEC
Feb 15, 2019Feb 15, 2019Loxo Oncology, Inc.Director, 10% ownerTendered2M$235.00$479M2MSEC
Feb 15, 2019Feb 15, 2019Loxo Oncology, Inc.Director, 10% ownerReturned to the companyEmployee Stock Option (Right to Buy)50,999$235.00$12M0SEC
Jan 2, 2019Jul 18, 2019Zosano Pharma CorpDirector, 10% ownerAwardedStock Option (Right to Buy)1,5001,500SEC
Jun 22, 2018Jun 25, 2018ADMADirectorAwardedStock Option (right to buy)17,50017,500SEC
Jun 13, 2018Jun 14, 2018Loxo Oncology, Inc.Director, 10% ownerAwardedDirector Stock Option (right to buy)8,7508,750SEC
May 17, 2018May 21, 2018Zosano Pharma CorpDirector, 10% ownerAwardedStock Option (right to buy)25,00025,000SEC
Nov 22, 2017Nov 27, 2017Loxo Oncology, Inc.Director, 10% ownerSold500,000$75.00$37.5M3.7MSEC
Jun 22, 2017Jun 23, 2017Loxo Oncology, Inc.Director, 10% ownerAwardedDirector Stock Option (right to buy)11,00011,000SEC
Jun 6, 2017Jun 8, 2017ADMADirector, 10% ownerAwardedStock Option (right to buy)53,83753,837SEC
Feb 14, 2017Feb 16, 2017ADMADirector, 10% ownerAwardedStock Option (right to buy)10,00010,000SEC
Jun 10, 2016Jun 13, 2016Loxo Oncology, Inc.Director, 10% ownerAwardedDirector Stock Option (right to buy)7,8127,812SEC
Page 1

Sales and notices (6)

Form 144 notices and Form 4 sales by Elms Steve
Source
Jun 16, 2025Jun 16, 2025ADMADirectorForm 4 sale425,621$8.8M17.3%No planSEC
Jun 12, 2025Jun 12, 2025ADMADirectorForm 144 notice425,621$9.3MNoticeSEC
Mar 19, 2024Mar 19, 2024ADMADirectorForm 4 sale461,716$2.8M17.9%No planSEC
Mar 15, 2024Mar 15, 2024ADMADirectorForm 4 sale1M$6.3M28.7%UnusualSEC
Nov 22, 2017Nov 27, 2017Loxo Oncology, Inc.Director, 10% ownerForm 4 sale500,000$37.5M11.9%Plan not statedSEC
Mar 10, 2010Mar 12, 2010MAP Pharmaceuticals, Inc.DirectorForm 4 sale2,090$34k100.0%UnusualSEC